Monitoring blood sugar is advised for diabetic patients
By targeting obesity first, healthcare providers can potentially improve or even resolve associated conditions like type 2 diabetes, hypertension, and dyslipidemia, she said
[7] [8] Patients should contact their healthcare provider immediately if they experience persistent vomiting, inability to maintain hydration, severe or persistent abdominal pain (which could indicate pancreatitis, a rare but serious side effect), bilious vomiting, signs of wound complications, or inability to keep fluids down
Regional Insights North America: the high prevalence of type 2 diabetes and obesity in North America paired with a strong emphasis on cutting-edge healthcare solutions are driving factors in the GLP-1 analogues market
| OZiva
It's not approved for use here because it's still in early trials as a potential treatment for obesity and related metabolic conditions